| BLK |
Report |
Organic Base Fee Growth (Q2 2026) |
BEAT |
pred ~1.55% qtrly vs. cons ~1.36% qtrly (VA, Jul 14 2026) |
MEDIUM |
| BLK |
Report |
Total Net Flows (Q2 2026) |
MISS |
pred ~$178B vs. cons $189.7B (VA, Jul 14 2026) |
MEDIUM |
| BLK |
Report |
Diluted EPS - Operating (Q2 2026) |
BEAT |
pred ~$13.15 vs. cons $12.69 (VA, Jul 14 2026) |
HIGH |
| BLK |
Guide |
Organic BFG Target (FY2026) |
BETTER |
guide 6-7% reaffirm vs. cons ~5.1% annualized (VA, Jul 14 2026) |
HIGH |
| BLK |
Guide |
Operating Margin (FY2026) |
UNCHANGED |
guide >=45% reaffirm vs. cons implied ~45.1% (VA, Jul 14 2026) |
HIGH |
| BLK |
Guide |
Private Markets Tone (FY2026) |
BETTER |
positive pipeline update; no formal raise vs. no prior formal guide |
MEDIUM |
| BLK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.0% |
— |
MEDIUM |
| BLK |
Return |
5-day cumulative residual |
+2.0% (FADE) |
FADE - flows miss pulls near-term estimates slightly lower; initial gap partially gives back over days 2-5 as sell-side trims Q3 flows models |
MEDIUM |